SUNFLOWER(SZ:300111) Xin Lang Cai Jing·2026-01-19 06:23Core Viewpoint - Zhejiang Sunflower Health Technology Co., Ltd. is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, following concerns about misleading statements in its restructuring proposal [1][5]. Group 1: Investigation and Legal Proceedings - On January 15, 2026, Zhejiang Sunflower announced it received a notice from the CSRC regarding the initiation of an investigation due to alleged violations of the Securities Law and Administrative Penalty Law [1][5]. - The CSRC's investigation was prompted by market doubts regarding the actual production capacity and business model of the restructuring target disclosed on September 22, 2025 [1][5]. - The Zhejiang Securities Regulatory Bureau has found that the restructuring proposal may contain misleading statements, leading to the ongoing investigation [1][5]. Group 2: Investor Compensation and Legal Actions - Investors who suffered losses due to the alleged violations can register for compensation claims through legal representation offered by Shanghai Hanlian Law Firm [2][6]. - The conditions for compensation claims include purchasing Sunflower stocks or bonds between September 22, 2025, and January 14, 2026, and selling or holding them after January 15, 2026 [2][6]. - Legal experts emphasize that while investors can file lawsuits without an administrative penalty decision, such a decision is still considered a necessary prerequisite for successful claims [3][7]. Group 3: Documentation for Claims - Investors seeking to register for compensation must provide specific documentation, including a copy of their ID, a securities account confirmation, and transaction records from the initial purchase to the present [8].